Big Win in Psoriasis for Dual IL-17A/17F Inhibitor Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
Don't Stop Taltz in Psoriatic Arthritis Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDs Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
Targeting IL-23 Relieves Multiple Symptoms in PsA Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
Psoriasis Cream Succeeds in Early Trial PDE-4 inhibitor helped clear plaque psoriasis in 6 weeks Jul 15, 2020
Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humira Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
EULAR 2020: What to Expect Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
Biologics Don't Increase Melanoma Risk... Probably Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
Guselkumab a Hit in Phase III for PsA Primary endpoints met in two large trials in psoriatic arthritis for IL-23 inhibitor Apr 10, 2020
Psoriasis IL-23 Biologic Maintains Efficacy in 2-Year Trial Phase III trial looked at risankizumab (Skyrizi) Apr 08, 2020
IL-31 Drug Succeeds for Prurigo Nodularis Less itching and twice as many lesions resolved with investigational agent Feb 19, 2020
Confirmed: TNF Inhibitors Don't Raise Cancer Risk Reassurance from national study in Denmark Dec 13, 2019
Reassurance on Live-Virus Shingles Vax With Anti-TNFs Randomized trial indicates fears of infection unfounded Nov 11, 2019
Psoriasis Model: Ketogenic Diets' Effects Not Equal Some fats affect the skin more than others, preclinical study suggests Nov 05, 2019
Got Psoriasis? Maybe Best to Avoid Certain Keto Diets Animal study suggests the two don't always play together nicely Oct 22, 2019
JAK Inhibitors Emerging as Oral Option for Psoriasis But older oral therapies remain key therapeutic players for many patients Oct 22, 2019
Chronic Itch: New Therapy, Complexities "End of the antihistamine era" as new strategies target neural mechanisms Oct 18, 2019
Can Anti-TNF Drugs Reduce Alzheimer's Risk? Analysis of 56 million patients hints at possible connections Oct 04, 2019
IL-17a Drug Rescues Many Refractory Psoriatic Arthritis Cases Disease abated in half of patients receiving secukinumab after failing other biologics Jun 14, 2019
No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
Cosentyx Safety Confirmed Through 5 Years Safety profile favorable in psoriasis, psoriatic arthritis, and ankylosing spondylitis May 04, 2019
Vitiligo, Alopecia Merely Cosmetic? Think Again Studies show links with depression, quality of life -- and early death Apr 18, 2019
Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time? Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
When Not to Use Biologics for Psoriasis Comorbidities, special populations, idiosyncrasies influence decisions Mar 06, 2019
IBD Rates Low in Patients on Cosentyx Analysis of data from 21 clinical trials in psoriasis, psoriatic arthritis, and ankylosing spondylitis Jan 25, 2019
Two-Drug Regimen Fails to Stem Psoriasis Relapse Study looks at costimulatory blockade with abatacept after stopping ustekinumab Dec 18, 2018
Skin Lesions Linked With Anti-TNF in IBD Most paradoxical psoriasiform eruptions were managed locally Dec 17, 2018
Skin-Stripping Test Promising for Inflammatory Skin Diseases Protein analysis may help differentiate between eczema, psoriasis Dec 16, 2018
PASDAS: Targeting Multiple Aspects of PsA Secukinumab showed efficacy for the various domains of psoriatic arthritis Dec 10, 2018
In Psoriatic Arthritis, Doubling Down on IL-17 Bimekizumab targets both IL-17A and F; "astonishing" results in psoriatic arthritis Oct 25, 2018
Psoriasis Response Falls as Comorbidities Rise Comorbid conditions reported in two-thirds of patients Sep 14, 2018
Minimal Disease Activity: The Goal in PsA Validity confirmed in large population of patients Jul 19, 2018
Enthesitis in PsA: A New Focus of Treatment? Targeting IL-23 with ustekinumab cleared enthesitis in three-quarters of patients Jun 22, 2018
